| Search |
| [Next Page] |
More on CW agent codes
Here's the paper in which the ring contration of esters of 3-hydroxy-N-alkylpiperidines e.g. Ditran ... |
15-7-2008 at 03:44
by: Sauron |
Biguanide plus Biuret
I'm personally very familiar with biguanide (guanylguanidine) since I am obliged to swallow a gram o ... |
15-7-2008 at 03:33
by: Sauron |
Chloroacetic Acid from TCCA and S/I2 Catalyst?
Amen to that. Nobody cares about the obstacles in the path of hobbyists except of course, other hobb ... |
15-7-2008 at 03:27
by: Sauron |
Chloroacetic Acid from TCCA and S/I2 Catalyst?
Of course you are quite right that using ROCl or ROBr rather than ROOH + halogen carrier is not prec ... |
15-7-2008 at 02:11
by: Sauron |
VX preparation
There is considerable confusion in what passes for the literature as to the Russian (Soviet era) equ ... |
15-7-2008 at 01:51
by: Sauron |
VX preparation
In the second to last step, the P=O bond of the "trans-ester" which you drew correctly, is thiated a ... |
14-7-2008 at 21:24
by: Sauron |
Less-than-lethal (LTL) anesthetic CW agents
Both carfentanyl and some of its very potent analogs, and also etorphine, could have been used, and ... |
14-7-2008 at 21:09
by: Sauron |
Less-than-lethal (LTL) anesthetic CW agents
The military incap agent BZ was not a benzodiazapine.
It is quite explicitly quinuclidin-3-yl ben ... |
14-7-2008 at 20:58
by: Sauron |
More on CW agent codes
Ah, but cancer chemotherapy got its very start owing to the development of the nitrogen "mustards" s ... |
14-7-2008 at 18:58
by: Sauron |
More on CW agent codes
Actually Biel published a paper in JACS in 1952 (three years prior to your citation) describing the ... |
14-7-2008 at 17:55
by: Sauron |
More on CW agent codes
Actually there are two different rearrangements:
The first is the ring expansion occuring duirng ... |
14-7-2008 at 09:48
by: Sauron |
VX preparation
Maybe. Maybe not. The Middle East is a big place, the Islamic world even bigger, and not everyone is ... |
14-7-2008 at 08:54
by: Sauron |
More on CW agent codes
The accident I am talking about was the discovery of the psychotomimetic effects as a consequence of ... |
14-7-2008 at 08:34
by: Sauron |
VX preparation
No problem. We were talking about two different things. |
14-7-2008 at 06:55
by: Sauron |
VX preparation
And PS, I would not make the MePF2 from PF3 and methane. That may be a valid industrial process, but ... |
14-7-2008 at 06:38
by: Sauron |
VX preparation
There was I time when I thought so as well. There was a time when the people at Edgewood thought so, ... |
14-7-2008 at 06:28
by: Sauron |
Chloroacetic Acid from TCCA and S/I2 Catalyst?
At the risk of repeating myself:
Any variation of the HVZ reaction is going to yield the chloroac ... |
14-7-2008 at 04:40
by: Sauron |
VX preparation
That is the most important of many patents on this series of compounds because it describes the actu ... |
14-7-2008 at 04:17
by: Sauron |
Chloroacetic Acid from TCCA and S/I2 Catalyst?
I posted that article 6 posts upthread, but never mind. I think it was you I got it from anyway, Nic ... |
14-7-2008 at 02:34
by: Sauron |
Less-than-lethal (LTL) anesthetic CW agents
All reports as to the identity of the Russian opioid agent are speculative. What is the ED50 or eto ... |
14-7-2008 at 00:35
by: Sauron |
More on CW agent codes
In the very first JACS paper describing the 3-hydroxypiperidyl benzilate antispamodics, Biel and cow ... |
14-7-2008 at 00:13
by: Sauron |
CBrCl3 -> CCl4 or CHCl3?
I agree Perhaps at the time of the original research the 730 filter was not available. |
13-7-2008 at 17:49
by: Sauron |
More on CW agent codes
Yeah I know that the assymetrical benzilate has two chiral centers, but I was referring to BZ itself ... |
13-7-2008 at 17:36
by: Sauron |
More on CW agent codes
The compound you have labeled as EA 3167 is the one Abood stated was most potent in the series.
N ... |
13-7-2008 at 09:30
by: Sauron |
More on CW agent codes
For further information I recommend you obtain the two part study entitled "Possible Long Term Healt ... |
13-7-2008 at 07:42
by: Sauron |
| [Next Page] |
